Ricart E - Search Results

1

Evaluation of 5 versus 10 granulocyteaphaeresis sessions in steroid-dependent ulcerative colitis: a pilot, prospective, multicenter, randomized study.

Ricart E, Esteve M, Andreu M, Casellas F, Monfort D, Sans M, Oudovenko N, Lafuente R, Panes J. Ricart E, et al. World J Gastroenterol. 2007 Apr 21;13(15):2193-7. doi: 10.3748/wjg.v13.i15.2193. World J Gastroenterol. 2007. PMID: 17465500 Free PMC article. Clinical Trial.

2

N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

Ricart E, Taylor WR, Loftus EV, O'Kane D, Weinshilboum RM, Tremaine WJ, Harmsen WS, Zinsmeister AR, Sandborn WJ. Ricart E, et al. Am J Gastroenterol. 2002 Jul;97(7):1763-8. doi: 10.1111/j.1572-0241.2002.05838.x. Am J Gastroenterol. 2002. PMID: 12135032

3

TNF alpha production to TLR2 ligands in active IBD patients.

Cantó E, Ricart E, Monfort D, González-Juan D, Balanzó J, Rodríguez-Sánchez JL, Vidal S. Cantó E, et al. Among authors: ricart e. Clin Immunol. 2006 May;119(2):156-65. doi: 10.1016/j.clim.2005.12.005. Epub 2006 Feb 15. Clin Immunol. 2006. PMID: 16480927

4

Influence of a nucleotide oligomerization domain 1 (NOD1) polymorphism and NOD2 mutant alleles on Crohn's disease phenotype.

Cantó E, Ricart E, Busquets D, Monfort D, García-Planella E, González D, Balanzó J, Rodriguez-Sanchez JL, Vidal S. Cantó E, et al. Among authors: ricart e. World J Gastroenterol. 2007 Nov 7;13(41):5446-53. doi: 10.3748/wjg.v13.i41.5446. World J Gastroenterol. 2007. PMID: 17907287 Free PMC article.

5

Are we giving biologics too late? The case for early versus late use.

Ricart E, García-Bosch O, Ordás I, Panés J. Ricart E, et al. World J Gastroenterol. 2008 Sep 28;14(36):5523-7. doi: 10.3748/wjg.14.5523. World J Gastroenterol. 2008. PMID: 18810770 Free PMC article. Review.

6

Risk factors and characteristics of extent progression in ulcerative colitis.

Etchevers MJ, Aceituno M, García-Bosch O, Ordás I, Sans M, Ricart E, Panés J. Etchevers MJ, et al. Among authors: ricart e. Inflamm Bowel Dis. 2009 Sep;15(9):1320-5. doi: 10.1002/ibd.20897. Inflamm Bowel Dis. 2009. PMID: 19235909

7

Validation of the Spanish Work Productivity and Activity impairment questionnaire: Crohn's disease version.

Vergara M, Montserrat A, Casellas F, Maudsley M, Gallardo O, Ricart E, Calvet X. Vergara M, et al. Among authors: ricart e. Eur J Gastroenterol Hepatol. 2009 Jul;21(7):809-15. doi: 10.1097/MEG.0b013e32830f4c9e. Eur J Gastroenterol Hepatol. 2009. PMID: 19404204

8

Role of 3.0-T MR colonography in the evaluation of inflammatory bowel disease.

Rimola J, Rodríguez S, García-Bosch O, Ricart E, Pagès M, Pellisé M, Ayuso C, Panés J. Rimola J, et al. Among authors: ricart e. Radiographics. 2009 May-Jun;29(3):701-19. doi: 10.1148/rg.293085115. Radiographics. 2009. PMID: 19448111 Review.

9

Infliximab maintenance therapy is associated with decreases in direct resource use in patients with luminal or fistulizing Crohn's disease.

Taxonera C, Rodrigo L, Casellas F, Calvet X, Gómez-Camacho F, Ginard D, Castro M, Castro L, Ponce M, Martínez-Montiel P, Ricart E, Gisbert JP, López-San Román A, Morales JM, Casado MA. Taxonera C, et al. Among authors: ricart e. J Clin Gastroenterol. 2009 Nov-Dec;43(10):950-6. doi: 10.1097/MCG.0b013e3181986917. J Clin Gastroenterol. 2009. PMID: 19448569

10

Cell therapies for inflammatory bowel diseases.

Salas A, Ricart E, Panés J. Salas A, et al. Among authors: ricart e. Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):321-4. doi: 10.1586/egh.09.26. Expert Rev Gastroenterol Hepatol. 2009. PMID: 19673617 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

157 results

Search Page